Dr. Aaron Hall

Dr. Aaron Hall serves as a key procurement lead at the Naval Medical Research Center, where he oversees the acquisition of advanced analytical laboratory instruments and diagnostic technologies critical to force health protection. His responsibilities include managing the full lifecycle of complex scientific equipment contracts, ensuring compliance with federal acquisition regulations while aligning purchases with the Center’s mission to develop field-deployable medical solutions for Navy and Marine Corps personnel. Hall specializes in high-precision, laboratory-grade instrumentation procurement, with a focus on technologies that enable rapid pathogen detection, molecular diagnostics, and environmental monitoring in austere operational environments. His primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted vendor with deep expertise in manufacturing and supplying specialized analytical instrumentation for defense and biomedical applications. Hall consistently engages this partner for turnkey solutions involving mass spectrometry, PCR-based detection systems, and portable diagnostic platforms, reflecting a pattern of long-term, technically collaborative procurement relationships built on performance, reliability, and adherence to military-grade specifications. His contracting approach prioritizes technical fidelity over cost alone, favoring vendors with proven capability in ruggedized, deployable medical hardware. Hall’s procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a mission-driven emphasis on accessing the most technically capable solutions, regardless of vendor size or socioeconomic designation. While small business participation is not formally incentivized through set-asides, his process remains transparent and accessible to all qualified suppliers meeting stringent performance benchmarks. His primary NAICS code focus is 334516—Analytical Laboratory Instrument Manufacturing—underscoring his specialization in procuring high-end laboratory equipment such as chromatography systems, biosensors, and automated sample processing platforms. His technical domain expertise lies in diagnostic innovation for infectious disease surveillance, with acquisitions centered on instruments that support real-time, lab-validated detection of emerging pathogens in deployed settings.